[ad_1] Vicor Corporation surged 11.6% on Tuesday to $158.84, riding a powerful rally that lifted sector peers across the board. The electronic components maker jumped alongside a basket of industry players, with six peers posting gains ranging from 3.5% to…
[ad_1] Consumer goods giant Unilever (LSE: ULVR) today (31 March) announced that it is in âadvanced discussionsâ with Schwartz owner McCormick about âa potential strategic transaction involving elements of its Foods businessâ. It then announced shortly afterwards that it has…
[ad_1] CF Industries Holdings plunged 6.2% on Tuesday as a wave of insider selling totaling $53.2 million over the past month rattled investor confidence. The agricultural inputs company’s stock closed at $128.95 on heavy volume of 4.4 million shares, as…
[ad_1] With oil prices rising and a high level of geopolitical uncertainty, many people are nervously eyeing the inflation rate. Higher inflation makes life even more expensive. That helps explain the attraction for many investors of power network operator National…
[ad_1] BKYI|EPS -$0.19|Rev $1.2M|Net Loss $1.7M Stock $0.53 (-11.5%) EPS YoY +58.7%|Rev YoY -15.1%|Net Margin -138.7% BIO-key International delivered a narrower quarterly loss but revenue deterioration accelerated, raising questions about near-term growth visibility despite management’s bullish Q1 outlook. The security…
[ad_1] Some investors take a very clear approach when it comes to investing their Self-Invested Personal Pension (SIPP). They focus on high-yield dividend shares and try to build substantial income streams, compounding the dividends along the way. This approach can…
[ad_1] JILL|EPS -$0.02 vs $0.60 est (-103.3%)|Rev $138.4M|Net Loss $3.5M Stock $10.84 EPS YoY -114.3%|Rev YoY -3.1%|Net Margin -2.5% Severe miss driven by tariff headwinds and promotional pressure. J.Jill, Inc. delivered adjusted loss per share of -$0.02 for Q4 2025,…
[ad_1] Only people not interested in the stock market — or living under a rock — are unaware that Nvidia has been a belting stock to own long term. We’re talking about a 19,028% return (in US dollar terms) over…
[ad_1] Arrowhead Pharmaceuticals surged 7.3% to $61.87 on Tuesday as a broad rally lifted biotechnology stocks across the sector. The $8.7 billion company rode a wave of bullish sentiment that pushed several sector peers sharply higher, with trading volume reaching…
[ad_1] With April starting tomorrow (1 April) â Iâm not joking â as always there is a lot of attention being paid to the annual ISA deadline. Not only is it on the minds of longstanding investors, it also sometimes…